主要收入构成
报告期:2023-12-31
主营产品构成(百万) |
名称 |
占总收入比例 |
收入 |
同比变化 |
成本 |
毛利率 |
同比变化 |
EMR/ESD类 |
14.55% |
350.85 |
37.94% |
131.59 |
62.49% |
6.22% |
ERCP类 |
7.17% |
172.87 |
57.60% |
70.30 |
59.33% |
-0.87% |
EUS/EBUS类 |
1.80% |
43.44 |
82.38% |
26.99 |
37.86% |
-6.83% |
代理 |
3.72% |
89.77 |
67.74% |
56.41 |
37.16% |
5.47% |
活检类 |
10.24% |
246.85 |
-1.37% |
151.33 |
38.69% |
4.07% |
可视化产品类 |
4.04% |
97.44 |
-48.78% |
62.20 |
36.17% |
-5.69% |
扩张类 |
8.80% |
212.15 |
13.56% |
56.21 |
73.50% |
3.45% |
其他 |
3.10% |
74.75 |
48.29% |
29.00 |
61.21% |
17.83% |
其他(补充) |
0.66% |
15.81 |
135.89% |
8.67 |
45.18% |
31.38% |
微波消融针 |
7.22% |
174.04 |
41.06% |
35.76 |
79.45% |
-1.57% |
止血及闭合类 |
38.21% |
921.37 |
27.07% |
218.45 |
76.29% |
0.69% |
肿瘤消融设备 |
0.50% |
12.14 |
107.70% |
9.06 |
25.37% |
-9.85% |
总计 |
2411.47 |
行业收入构成(百万) |
名称 |
占总收入比例 |
收入 |
同比变化 |
成本 |
毛利率 |
同比变化 |
其他(补充) |
0.66% |
15.81 |
135.89% |
8.67 |
45.18% |
31.38% |
医疗器械 |
99.34% |
2395.66 |
21.39% |
847.31 |
64.63% |
3.52% |
总计 |
2411.47 |
地区收入构成(百万) |
名称 |
占总收入比例 |
收入 |
同比变化 |
成本 |
毛利率 |
同比变化 |
内销 |
56.13% |
1353.47 |
18.21% |
467.06 |
65.49% |
4.04% |
其他(补充) |
0.66% |
15.81 |
135.89% |
8.67 |
45.18% |
31.38% |
外销 |
43.22% |
1042.19 |
25.80% |
380.26 |
63.51% |
2.87% |
总计 |
2411.47 |